The TGA saw an increase in firms using digital platforms and telehealth services to breach advertising rules in FY23, but only seven were fined.
In its Therapeutic Goods Advertising Compliance Annual Report 2022-23 the regulator said it observed an increase in the use of third-party platforms (such as media outlets and online business profiles), websites and social media platforms to unlawfully promote the supply and use of medicinal cannabis products.
It said it also saw an increase in the promotion of therapeutic goods in conjunction with the promotion of telehealth services relating to the prescription of medicinal cannabis.
It received 362 allegations of non-compliance during the year, removed 351 alleged unlawful advertisements from digital platforms and issued 101 infringement notices totalling A$1,292,040 to seven entities.
